SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
Commission File Number: 333-148833
NOTIFICATION OF LATE FILING
(Check One):
[X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D
[ ] Form N-SAR [ ] Form N-CSR
For Period Ended: December 31, 2009
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: N/A
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates: N/A
PART I. REGISTRANT INFORMATION
Full name of registrant: SPECTRUMDNA, INC.
Former name if applicable: N/A
Address of principal executive office (Street and number):
1700 Park Avenue, Suite 2020, PO Box 682798
City, State and Zip Code:
Park City, UT 84068
Page 1 of 3
Part II. RULES 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check appropriate box.)
[x] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[x] (b) The subject annual report, semi-annual report, transition report on Form
10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will
be filed on or before the 15th calendar day following the prescribed due date;
or the subject quarterly report or transition report on Form 10-Q or subject
distribution report on Form 10-D, or portion thereof will be filed on or before
the fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III. NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be
filed within the prescribed time period.
SEE RIDER ANNEXED HERETO.
PART IV. OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification: Name: Rebecca D. Hershinger Area Code and Telephone Number: (435)
658-1349
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) been filed? If the answer is no,
identify report(s). [X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[X] Yes [ ] No
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
SPECTRUMDNA, INC. has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: March 31, 2010 BY: /s/ James A. Banister
---------------------
Name: James A. Banister
Title: Chief Executive Officer
|
Page 2 of 3
ATTENTION
INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL
VIOLATIONS (SEE 18 U.S.C. 1001).
SPECTRUMDNA, INC.
RIDER TO FORM 12b-25
PART III - NARRATIVE
The Registrant's Annual Report on Form 10-K for the year ended December 31, 2009
cannot be filed within the prescribed time period because the Registrant
requires additional time for compilation and review to insure adequate
disclosure of certain information required to be included in the Form 10-K. The
Registrant's Annual Report on Form 10-K will be filed on or before the 15th
calendar day following the prescribed due date.
PART IV - OTHER INFORMATION
(3) The Registrant anticipates that its revenues for the year ended December 31,
2009 will be approximately $150,000 compared to revenues of $68,000 achieved
during the year ended December 31, 2008. The revenues in 2009 resulted from
sales relating to the Addictionary enginet and various service functions. During
the year ended December 31, 2008, we had a net loss of $2,559,000 and we
anticipate our net loss will be $2,433,000 for 2009. Such decrease in our net
loss is primarily due to increased revenues and decreases in operating expenses
offset by an increase in interest expense.
Page 3 of 3
SpectrumDNA (CE) (USOTC:SPXA)
Historical Stock Chart
From May 2024 to Jun 2024
SpectrumDNA (CE) (USOTC:SPXA)
Historical Stock Chart
From Jun 2023 to Jun 2024